vimarsana.com

Latest Breaking News On - Global specialty drug insurance - Page 1 : vimarsana.com

Hexvix®, A Diagnostic Drug of Asieris, is Now Covered by the 2022 Lecheng Global Specialty Drug Insurance

/PRNewswire/ Asieris Pharmaceuticals (688176.SH), a global biopharma company specializing in discovering, developing and commercializing innovative drugs.

United statesXinming jiangSecurity bureau of hainan provinceHainan office of china bankingChinese urological association guidelinePrnewswire asieris pharmaceuticalsAsieris pharmaceuticalsNational medical products administrationInsurance regulatory commissionGlobal specialty drug insuranceHainan officeChina bankingMedical security bureauChinese urological associationHainan provinceHainan general hospital

Photocure Partner Asieris announces coverage of Hexvix by the Lecheng Global Specialty Drug Insurance

Press release - Oslo, Norway, September 15, 2022: Photocure ASA , The Bladder Cancer Company, announces that its partner Asieris Pharmaceuticals has communicated today on the inclusion of Hexvix®. | September 15, 2022

Hainan provinceUnited statesNew zealandErik dahlDan schneiderDavid moskowitzCysview hexvixHexvix cysviewAsieris pharmaceuticalsBladder cancer companyCorporate communicationsBoao lecheng international medical tourism pilot zoneNational medical products administrationAmerican cancer societyOslo stock exchangeGlobal specialty drug insurance

vimarsana © 2020. All Rights Reserved.